Related Experiment Video

Updated: May 25, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Developing microRNA therapeutics

Eva van Rooij1, Angela L Purcell, Arthur A Levin

  • 1miRagen Therapeutics, Inc, Boulder, CO 80301, USA. eva.vanrooij@miragentherapeutics.com

Circulation Research
|February 4, 2012
PubMed

Insights

MicroRNAs (miRNAs) show therapeutic potential due to their disease involvement and efficacy. This review covers miRNA targets, therapeutic development, and the commercial landscape for these novel drug targets.

Area of Science:

  • Biochemistry and Molecular Biology
  • Genetics and Genomics
  • Pharmacology

Background:

  • MicroRNAs (miRNAs) have rapidly emerged as a significant research area.
  • Despite ongoing basic research, their therapeutic potential is increasingly recognized.
  • miRNAs are implicated in various human diseases, driving biotechnological interest.

Purpose of the Study:

  • To provide an overview of current miRNA targets.
  • To outline the process of developing miRNAs into therapeutic modalities.
  • To summarize the patent landscape and key companies in miRNA therapeutics.

Main Methods:

  • Literature review of current miRNA research and therapeutic development.
  • Analysis of scientific publications and patent filings.
  • Survey of biotechnology companies involved in miRNA drug discovery.

Main Results:

  • Identification of key biological pathways targeted by miRNAs.
  • Overview of strategies for translating miRNA discoveries into clinical applications.
  • Summary of the competitive landscape, including major players and patent trends.

Conclusions:

  • MicroRNAs represent a promising class of therapeutic agents.
  • The transition from bench discovery to therapeutic development is feasible.
  • Significant commercial interest and investment are evident in the miRNA field.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...